Gal Markel

11.4k total citations
126 papers, 5.8k citations indexed

About

Gal Markel is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Gal Markel has authored 126 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Immunology, 59 papers in Oncology and 36 papers in Molecular Biology. Recurrent topics in Gal Markel's work include CAR-T cell therapy research (34 papers), Immunotherapy and Immune Responses (32 papers) and Immune Cell Function and Interaction (31 papers). Gal Markel is often cited by papers focused on CAR-T cell therapy research (34 papers), Immunotherapy and Immune Responses (32 papers) and Immune Cell Function and Interaction (31 papers). Gal Markel collaborates with scholars based in Israel, United States and Italy. Gal Markel's co-authors include Ofer Mandelboim, Jacob Schachter, Michal J. Besser, Gil Katz, Tal I. Arnon, Orit Itzhaki, Ronnie Shapira‐Frommer, Roi Gazit, Jacob H. Hanna and Avraham J. Treves and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Gal Markel

125 papers receiving 5.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gal Markel Israel 41 3.0k 2.5k 1.5k 509 503 126 5.8k
Shaun O’Brien United States 22 2.1k 0.7× 2.6k 1.0× 1.5k 1.0× 284 0.6× 210 0.4× 44 4.9k
Michal Lotem Israel 29 1.8k 0.6× 3.4k 1.3× 1.9k 1.2× 286 0.6× 257 0.5× 106 4.9k
Barbara Pro United States 47 2.4k 0.8× 5.3k 2.1× 1.6k 1.0× 522 1.0× 554 1.1× 289 9.9k
Pierluigi Porcu United States 42 2.2k 0.7× 2.7k 1.0× 1.8k 1.2× 713 1.4× 208 0.4× 289 7.1k
Steven E. Finkelstein United States 32 4.1k 1.4× 4.0k 1.6× 982 0.6× 284 0.6× 568 1.1× 71 6.6k
Felipe Samaniego United States 47 1.2k 0.4× 3.2k 1.3× 2.1k 1.4× 549 1.1× 268 0.5× 217 7.3k
Colleen Simpson United States 14 4.2k 1.4× 3.8k 1.5× 1.2k 0.8× 345 0.7× 510 1.0× 19 7.0k
Leah Haworth United States 12 2.5k 0.8× 3.2k 1.3× 2.0k 1.3× 243 0.5× 354 0.7× 21 6.1k
Steven L. Allen United States 45 4.5k 1.5× 1.9k 0.7× 3.2k 2.1× 412 0.8× 1.1k 2.2× 225 11.4k
Marco Bregni Italy 45 2.4k 0.8× 4.7k 1.8× 2.0k 1.3× 331 0.7× 573 1.1× 193 10.0k

Countries citing papers authored by Gal Markel

Since Specialization
Citations

This map shows the geographic impact of Gal Markel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gal Markel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gal Markel more than expected).

Fields of papers citing papers by Gal Markel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gal Markel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gal Markel. The network helps show where Gal Markel may publish in the future.

Co-authorship network of co-authors of Gal Markel

This figure shows the co-authorship network connecting the top 25 collaborators of Gal Markel. A scholar is included among the top collaborators of Gal Markel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gal Markel. Gal Markel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Markel, Gal, et al.. (2024). Peptriever: a Bi-Encoder approach for large-scale protein–peptide binding search. Bioinformatics. 40(5). 2 indexed citations
2.
Markovits, Ettai, Erez N. Baruch, Eldad D. Shulman, et al.. (2023). MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2. Cancer Immunology Research. 11(7). 909–924. 8 indexed citations
3.
Meirson, Tomer, Gilli Galore-Haskel, Ettai Markovits, et al.. (2022). Adenosine-Deaminase-Acting-on-RNA-1 Facilitates T-cell Migration toward Human Melanoma Cells. Cancer Immunology Research. 10(9). 1127–1140. 8 indexed citations
4.
Harel, Michal, Shun Yu, Ettai Markovits, et al.. (2021). Clinical Proteomics of Metastatic Melanoma Reveals Profiles of Organ Specificity and Treatment Resistance. Clinical Cancer Research. 27(7). 2074–2086. 14 indexed citations
5.
Meirson, Tomer, David Bomze, & Gal Markel. (2020). Structural basis of SARS-CoV-2 spike protein induced by ACE2. Bioinformatics. 37(7). 929–936. 21 indexed citations
6.
Itzhaki, Orit, Elad Jacoby, Arnon Nagler, et al.. (2020). Head-to-head comparison of in-house produced CD19 CAR-T cell in ALL and NHL patients. Journal for ImmunoTherapy of Cancer. 8(1). e000148–e000148. 37 indexed citations
7.
Galore-Haskel, Gilli, Eyal Greenberg, Inbal Yahav, et al.. (2020). microRNA expression patterns in tumor infiltrating lymphocytes are strongly associated with response to adoptive cell transfer therapy. Cancer Immunology Immunotherapy. 70(6). 1541–1555. 6 indexed citations
8.
Eshet, Yael, Erez N. Baruch, Ronnie Shapira‐Frommer, et al.. (2018). Clinical Significance of Pancreatic Atrophy Induced by Immune-Checkpoint Inhibitors: A Case–Control Study. Cancer Immunology Research. 6(12). 1453–1458. 46 indexed citations
9.
Ortenberg, Rona, Sivan Sapoznik, Douglas Zippel, et al.. (2015). Serum CEACAM1 Elevation Correlates with Melanoma Progression and Failure to Respond to Adoptive Cell Transfer Immunotherapy. Journal of Immunology Research. 2015. 1–8. 12 indexed citations
10.
Besser, Michal J., Ronnie Shapira‐Frommer, Orit Itzhaki, et al.. (2013). Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma: Intent-to-Treat Analysis and Efficacy after Failure to Prior Immunotherapies. Clinical Cancer Research. 19(17). 4792–4800. 294 indexed citations
11.
Burazor, Ivana, Massimo Imazio, Gal Markel, & Yehuda Adler. (2013). Malignant Pericardial Effusion. Cardiology. 124(4). 224–232. 70 indexed citations
12.
Ortenberg, Rona, Liat Hershkovitz, Sivan Sapoznik, et al.. (2012). Novel Immunotherapy for Malignant Melanoma with a Monoclonal Antibody That Blocks CEACAM1 Homophilic Interactions. Molecular Cancer Therapeutics. 11(6). 1300–1310. 59 indexed citations
13.
Zippel, Douglas, Michal J. Besser, Alon Ben‐Nun, et al.. (2012). Adoptive cell therapy with autologous tumor-infiltrating lymphocytes and high-dose interleukin-2 for metastatic melanoma: The surgeon’s perspective. Experimental and Therapeutic Medicine. 3(5). 898–902. 12 indexed citations
14.
Besser, Michal J., Ronnie Shapira‐Frommer, Avraham J. Treves, et al.. (2010). Clinical Responses in a Phase II Study Using Adoptive Transfer of Short-term Cultured Tumor Infiltration Lymphocytes in Metastatic Melanoma Patients. Clinical Cancer Research. 16(9). 2646–2655. 352 indexed citations
15.
Markel, Gal, Michal J. Besser, Kfir Oved, et al.. (2009). Preclinical evaluation of adoptive cell therapy for patients with metastatic renal cell carcinoma.. PubMed. 29(1). 145–54. 33 indexed citations
16.
Markel, Gal, Rachel Seidman, Gil Katz, et al.. (2006). Inhibition of Human Tumor-Infiltrating Lymphocyte Effector Functions by the Homophilic Carcinoembryonic Cell Adhesion Molecule 1 Interactions. The Journal of Immunology. 177(9). 6062–6071. 49 indexed citations
17.
Katz, Gil, Roi Gazit, Tal I. Arnon, et al.. (2004). MHC Class I-Independent Recognition of NK-Activating Receptor KIR2DS4. The Journal of Immunology. 173(3). 1819–1825. 81 indexed citations
18.
Gonen‐Gross, Tsufit, Hagit Achdout, Roi Gazit, et al.. (2003). Complexes of HLA-G Protein on the Cell Surface Are Important for Leukocyte Ig-Like Receptor-1 Function. The Journal of Immunology. 171(3). 1343–1351. 118 indexed citations
19.
Achdout, Hagit, Tal I. Arnon, Gal Markel, et al.. (2003). Enhanced Recognition of Human NK Receptors After Influenza Virus Infection. The Journal of Immunology. 171(2). 915–923. 63 indexed citations
20.
Markel, Gal, Dana G. Wolf, Jacob H. Hanna, et al.. (2002). Pivotal role of CEACAM1 protein in the inhibition of activated decidual lymphocyte functions. Journal of Clinical Investigation. 110(7). 943–953. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shaun O’Brien Breakdown of academic impact, for papers by Michal Lotem Breakdown of academic impact, for papers by Barbara Pro Breakdown of academic impact, for papers by Pierluigi Porcu Breakdown of academic impact, for papers by Steven E. Finkelstein Breakdown of academic impact, for papers by Felipe Samaniego Breakdown of academic impact, for papers by Colleen Simpson Breakdown of academic impact, for papers by Leah Haworth Breakdown of academic impact, for papers by Steven L. Allen Breakdown of academic impact, for papers by Marco Bregni
Rankless by CCL
2026